Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1743-422X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Analytical technologies for influenza virus-like particle candidate vaccines: challenges and emerging approaches ; volume:10 ; number:1 ; day:4 ; month:5 ; year:2013 ; pages:1-14 ; date:12.2013
Virology journal ; 10, Heft 1 (4.5.2013), 1-14, 12.2013
- Urheber
-
Thompson, Christine M.
- Beteiligte Personen und Organisationen
-
Petiot, Emma
Lennaertz, Alexandre
Henry, Olivier
Kamen, Amine A.
SpringerLink (Online service)
- DOI
-
10.1186/1743-422X-10-141
- URN
-
urn:nbn:de:1111-2016050111384
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Thompson, Christine M.
- Petiot, Emma
- Lennaertz, Alexandre
- Henry, Olivier
- Kamen, Amine A.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Vaccines for pandemic influenza
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
Influenza vaccines for the future
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Better influenza vaccines: an industry perspective
Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections
Universal label‐free in‐process quantification of influenza virus‐like particles
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization
Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea
Virus-like particle based vaccines : stabilization by freeze-drying and development of sustained release devices
Vaccines for pandemic influenza
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
Influenza vaccines for the future
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Better influenza vaccines: an industry perspective
Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections
Universal label‐free in‐process quantification of influenza virus‐like particles
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization
Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea
Virus-like particle based vaccines : stabilization by freeze-drying and development of sustained release devices
Vaccines for pandemic influenza
Plant-derived virus-like particle vaccines drive cross-presentation of influenza A hemagglutinin peptides by human monocyte-derived macrophages
Influenza vaccines for the future
Bacterial superglue enables easy development of efficient virus-like particle based vaccines
Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity
Better influenza vaccines: an industry perspective
Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections
Universal label‐free in‐process quantification of influenza virus‐like particles
Virus-like vaccines against HIV/SIV synergize with a subdominant antigen T cell vaccine
Structural analysis of influenza vaccine virus-like particles reveals a multicomponent organization
Cost Effectiveness of Quadrivalent Influenza Vaccines Compared with Trivalent Influenza Vaccines in Young Children and Older Adults in Korea